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Summary 
Interleukin (Ib12) has many effects on the function of natural killer and T cells, and is important 
in the control of cell-mediated immunity. IL-2 and IL-12 display many similar activities,  yet 
each also induces a distinct set of responses. A human IL-12 receptor subunit has recently been 
cloned and, like the IL-2R,8 and IL-2R% is a member of the hematopoietic receptor superfamily; 
however, the molecular mechanisms of IL-12 action are unknown. In this report we show that 
IL-12 and IL-2 induce tyrosine phosphorylation of distinct members of the Janus OAK) family 
of protein tyrosine kinases in human T lymphocytes. IL-12, but not IL-2, stimulates the tyrosine 
phosphorylation of TYK2 and JAK2, whereas JAK1 and JAK3, which are phosphorylated in 
response to IL-2, are not phosphorylated after IL-12 treatment. The use of distinct but related 
JAK family tyrosine kinases by IL-12 and IL-2 may provide a biochemical basis for their different 
biological activities. 
I 
L-12 is a recently characterized cytokine important in the 
control of cell-mediated immunity (1,  2).  Produced by 
monocytes, macrophages, and possibly other accessory cells 
(e.g., B cells), in response to bacteria, bacterial products, or 
intracellular parasites (3, 4), IL-12 has multiple effects on both 
NK and T cells. Among these, 11,-12 induces cytokine produc- 
tion (most notably IFN-3~), enhances cytotoxidty, and stimu- 
lates proliferation in combination with other activators such 
as IL-2 (1, 2, 5-8). The functional relationship between IL-2 
and IL-12 is complex; while the two cytokines share many 
biological effects, each also induces a distinct set of responses. 
For example, while both IL-2 and IL-12 directly enhance cyto- 
toxic activity and cellular adhesion molecule expression by 
NK cells (7), only IL-2 is mitogenic when used alone (7). 
Similarly, both IL-2 and IL-12 induce IFN-3, gene expres- 
sion and secretion by NK and T cells (6), yet only IL-12 can 
promote differentiation of CD4 + T cells to the Thl pheno- 
type (9). 
The molecular mechanisms of IL-12 action are poorly un- 
derstood. The recently cloned low-affinity IL-12  receptor 
subunit is a member of the hematopoietin receptor superfam- 
ily, closely related to gp130 (10). This family also includes 
the B and "y subunits of the IL-2 receptor (11). Although 
these receptors lack intrinsic tyrosine kinase activity,  rapid 
tyrosine phosphorylation of multiple cellular substrates is a 
common and requisite intracellular  event in their signaling 
pathways (12). Recent studies have suggested that this phos- 
phorylation may be mediated in large part by members of 
a newly described family of cytoplasmic protein tyrosine ki- 
nases (PTKs), the Janus (JAK) kinases (13, 14). To date, four 
JAK family members have been identified: JAK1 (15), JAK2 
(16), JAK3 (17), and TYK2 (18). Genetic complementation 
experiments have demonstrated the requirement for both JAK1 
and TYK2 in IFN-a signal transduction (19, 20),  and for 
both JAK1 and JAK2 in the IFN-3/pathway (19, 21); and 
biochemical studies  have shown that JAK1 and JAK2 are 
coupled to many of the hematopoietin receptors (22,  23). 
Furthermore, we and others have recently demonstrated that 
IL-2 stimulation of T and NK cells results in tyrosine phos- 
phorylation of JAK1  and JAK3,  elevation  of JAK3 phos- 
photransferase activity, and association of  JAK3 with IL-2R 
(24, 25). 
It was recently reported that IL-12 can induce protein tyro- 
sine phosphorylation in human T  cells (26);  however,  the 
role of JAK family kinases in IL-12 signaling remains un- 
known. In this study we show tyrosine phosphorylation of 
multiple substrates  after  IL-12 stimulation of human lym- 
phocytes, describe differences in the patterns of phosphoryla- 
tion induced by IL-12 and IL-2,  and show that while IL-2 
induced phosphorylation of JAK1 and JAK3, IL-12 induced 
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and JAK3. These data implicate TYK2 and JAK2 in the IL- 
12 signaling pathway and suggest a biochemical basis for the 
different  functions  of IL-2  and  IL-12. 
Materials  and Methods 
Reagents.  Recombinant human Ib12 (sp act 4.5  x  106 U/mg) 
was the generous gift of Dr. Stanley Wolf  (Genetics Institute, Cam- 
bridge,  MA).  Recombinant  human  Ib2 (18  x  106 IU/ml) was 
kindly provided by Cetus Oncology Corporation (Emeryville, CA). 
Recombinant  human  IFN-7  (2.02  x  107 IU/mg)  was  kindly 
provided by Dr. H. Michael Shepard (Genetech Laboratories, San 
Francisco, CA).  Recombinant  human  IFN-c~ (2.4  x  10  s U/mg) 
was generously provided by Hoffmann-LaRoche, Inc. (Nutley, NJ). 
Polyclonal rabbit  antisera against JAK1, JAK2,  and TYK2, and 
monoclonal anti-phosphotyrosine  antibody 4G10 were purchased 
from Upstate  Biotechnology, Inc. (Lake Placid, NY). Polyclonal 
rabbit  antiserum  against JAK3 has been described (17). 
Cell Culture and Activation.  Human T cells (94  •  5% CD3*) 
were isolated from peripheral blood of normal healthy consenting 
donors by Percoll gradient centrifugation  as previously described 
(27) and cultured  for 3 d with 2/~g/rnl  PHA (Sigma Chemical 
Co., St. Louis, MO). The IL-12-responsive human  NK cell line 
NK3.3 (28; Young, H. A., manuscript in preparation) was gener- 
ously provided by Dr. J.  Kombluth (Arkansas Cancer  Research 
Center, Little Rock, AR) and grown in RPMI medium with 15% 
FCS further  supplemented with 10% Lymphocult-T (Biotest Di- 
agnostics Corp., Denville, NJ) and 20 U/ml Ib2. Before stimula- 
tion, cells were washed in acidified RPMI (pH 6.4) and rested for 
24 h in ILPMI with 2% FCS. 
ImmunopreciFitation and Immunoblotting.  Stimulated cells were 
washed before being lysed in buffer containing 0.5% Triton X-100 
as previously described (24, 29). Clarified lysates were immuno- 
precipitated with anti-JAK1,  -JAK2,  -TYK2, or -JAK3 antisera 
conjugated  to protein  A-coupled  Sepharose beads, or with anti- 
phosphotyrosine mAb conjugated to protein G-coupled Sepharose 
beads. The immunoprecipitates  were resolved on 8% SDS-poly- 
acrylamide gels and transferred to Immobilon  (Millipore Corp., 
Bedord, MA) (29). 
For immunoblotting with antiphosphotyrosine, membranes were 
blocked in Tris-buffered saline (TBS) containing  1% fish gelatin, 
2% goat serum, 0.1% BSA, and 0.5% Tween 20 and sequentially 
incubated with antiphosphotyrosine  antibody, biotinyhted goat 
anti-mouse IgG (Oncogene Science, Inc., Cambridge,  MA), and 
horseradish perc0ddase--conjugated streptavidin (Oncogene Science, 
Inc.). Detection was performed by use of enhanced chemilumines- 
cence (ECL; Amersham,  Arlington  Heights,  IL). 
For immunoblotting  with  antibodies  to JAK family kinases, 
membranes were blocked in TBS containing 0.1% Tween and 5% 
nonfat dried milk, incubated sequentially with primary antibody 
and horseradish peroxidase--conjugated  goat anti-rabbit IgG (Boeh- 
ringer Mannheim, Indianapolis, IN), and detected with ECL. When 
a membrane was reprobed, it was first treated with 15% H202. 
Results 
IL-12,  but not IL-2, Induces Tyrosine Phosphorflation of the 
JAK Family Kinases TYK2 andJAK2 in Human T Cells.  IL- 
12 and IL-2 have similar yet distinct biological effects on human 
T  and  NK cells.  To investigate  the biochemical  events in- 
duced in human T  cells by stimulation with IL-12 or IL-2, 
lysates  were  immunoprecipitated  with  antibody  to  phos- 
photyrosine and analyzed by antiphosphotyrosine immuno- 
blotting. As shown in Fig.  1, stimulation with IL-12 (lanes 
2-5) caused increased tyrosine phosphorylation of a number 
of substrates compared with untreated control cells (lane 1). 
These substrates were each phosphorylated with similar ki- 
netics: maximal phosphorylation was observed within 5 min, 
and this was maintained  for 30 rain of stimulation.  While 
many proteins phosphorylated in response to IL-12 were also 
phosphorylated in response to IL-2 (Fig.  1,  lane 6),  differ- 
ences were observed in the tyrosine phosphorylation of pro- 
teins with  apparent  molecular masses of 120-140 kD.  One 
of the most prominent substrates, a phosphoprotein of'~135 
kD that was not detectable by antiphosphotyrosine  immu- 
noblotting  in  unstimulated  cells,  became  strongly  phos- 
phorylated after  stimulation  with  IL-12,  but  not  IL-2. 
The JAK family of cytoplasmic PTKs,  which  have been 
implicated  in  signaling  by  the  hematopoietin  family  of 
receptors,  have molecular masses between 120 and  140 kD. 
Moreover, we recently have shown that IL-2 causes tyrosine 
phosphorylation ofJAK3 andJAK1 (24). We therefore sought 
to  establish  whether JAK family proteins  were also phos- 
phorylated in response to IL-12. Since the 135-kD substrate 
was of the approximate molecular mass of TYK2, the anti- 
phosphotyrosine immunoprecipitates  shown in Fig.  1 were 
reprobed  with  antiserum  to  TYK2  (Fig.  2  A).  A  single 
band corresponding to the 135-kD phosphoprotein was de- 
Figure  1.  Ib12 and Ib2 induce  distinct patterns of tyrosine  phosphory- 
lation in human T cells. PHA-activated  human T cells (2  x  107)  were 
incubated for the indicated times in medium alone (lane I), with 100 U/ml 
Ib12 (lanes 2-5), or with 1,000 U/ml lb2 (lane 6) and lysates  immuno- 
precipitated with antiphosphotyrosine  mAb. The immunoprecipitates  were 
resolved by SDS-PAGE and analyzed by antiphosphotyrosine immuno- 
blotting. 
400  Phosphorylation  of JAK2 and TYK2 by Ib12 Figure  2.  ID12 induces phosphorylation  of JAK family kinases JAK2 and TYK2. (A) Anti-TYK2 immunoblotting: the blot of antiphosphotyrosine 
precipitates from IL-12- (lanes 2-5) and Ib2- (lane 6) activated T cells shown in Fig. I was reprobed with antiserum to TYK2. (B) Antiphosphotyrosine 
immunoblotting of anti-TYK2 immunoprecipitates:  PHA-activated human T  cells (2  x  107) were incubated  for 15 min in medium alone (lane 1), 
with 100 U/m11612 (lane 2), or with 1,000 U/m] IFN-a (lane 3), and lysates immunoprecipitated  with anti-TYK2 antiserum.  The immunoprecipitates 
were tzsolved  by SDS-PAGE  and anab/zed  by antiphosphotyrosine immunoblotting.  (C) Antiphosphotyrosine immunoblotting of anti-JAK2 immunoprecipi- 
hates: PHA-activated human T cells (2  x  10  T) were incubated  for 15 min in medium alone (lane I), with 100 U/ml II--12  (lane 2), with 1,000 U/ml 
IFN-a (lane 3), or with 1,000 U/ml Ib2 (Lanes 4 and 5).  Lysates were precleared with a control antiserum  (lanes 1-3 and 5) or with antiserum  to 
JAK3 (Lane  4) and then immunoprecipitated with anfisenam to JAK2. The immunoprecipitates were resohaxt  by SDS-PAGE  and analyzed  by antiphosphotyro- 
sine immunoblotting. (D) Anti-JAK2 iramunoblotting of antiphosphotyrosine  immunoprecipitates:  the blot of antiphosphotyrosine  precipitates from 
lb12-  (lanes 2-5) and Ib2- (lane 6) activated T  cells shown in Fig.  1 was reprobed with antiserum  to JAK2. 
tected only in antiphosphotyrosine  immunoprecipitates  from 
cells stimulated with IL-12  (Fig.  2 A,  lanes 2-5)  and not 
from unstimulated cells  (lane  1)  or  cells  stimulated with 
IL-2 (lane 6), 
To further confirm the 135-kD phosphoprotein as TYK2, 
the converse approach was used. Lysates of unstimulated or 
cytokine-stimulated T  cells were immunoprecipitated with 
antibody against TYK2 followed by antiphosphotyrosine  im- 
munoblotting. As shown in Fig.  2 B, TYK2 kinase from 
IL-12-stimulated T cells (lane 2) was phosphorylated on tyro- 
sine residues, whereas that from unstimulated cells (lane 1) 
was not. In agreement with previous reports (19, 30), tyro- 
sine phosphorylation of TYK2 was also observed in these 
cells in response to IFN-~ (Fig. 2 B, lane 3). However, con- 
sistent with our previous findings (24)  and with the data 
presented in Fig. 2 A, TYK2 immunoprecipitated from IL- 
2-stimulated T cells was not tyrosine phosphorylated (data 
not shown). 
Several cytokines (including IL-2, IL-6, IFN-ot, and IFN~) 
have been shown to be linked to more than one JAK family 
kinase in the same cell (19, 22, 24). We thus examined whether 
other JAK family kinases were phosphorylated in T cells in 
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kinase was tyrosine phosphorylated in immunoprecipitates 
from IL-12-treated cells (lane 2) but not from unstimulated 
cells (lane 1). IFN-3, similarly induced tyrosine phosphory- 
lation of  JAK2 (lane 3). The response to IL-2 is more com- 
plicated as the commercial anti-JAK2  antiserum cross-reacts 
with JAK3. Neverthdess, the two kinases can be distinguished 
by their molecular weights (25). Immunoprecipitation  ofly- 
sates from IL-2-stimulated cells with this antiserum thus re- 
vealed  a  tyrosine phosphoprotein of 125-kD,  JAK3,  but 
showed no phosphorylation of JAK2 itself (Fig.  2 C, lane 
5). Preclearing oflysate from IL-2-treated cells with antiserum 
to  JAK3  before  immunoprecipitation  with  anti-JAK2 
confirmed the identity of the 125-kD band as JAK3 and not 
JAK2 (lane  4). 
To verify that the 130-kD protein phosphorylated in re- 
sponse to IL-12 (Fig. 1) was JAK2, the same blot shown in 
this figure was stripped a second time and reprobed with an- 
tiserum to JAK2 (Fig. 2 D). A single band migrating exactly 
with the 130-kD protein was detected in the antiphosphotyro- 
sine immunoprecipitates from IL-12-activated cells (Fig.  2 
D, lanes 2-5) but not from unstimulated cells (lane I) or IL- 
2-stimulated cells (lane 6),  confirming that this protein is 
indeed JAK2,  Again, a  125-kD  band was detected in an- 
tiphosphotyrosine immunoprecipitates from IL-2-stimulated 
cells  (Fig.  2  D,  lane  6)  representing cross-reactive  phos- 
phorylatedJAK3 protein as discussed above. These data indi- 
cate that IL- 12, but not IL-2, is able to induce rapid tyrosine 
phosphorylation of the Janus family PTKs, TYK2 and JAK2. 
In Contrast to IL-2, 11.,-12 Does Not Induce Tyrosine Phos- 
phorylation of  theJAK Family  ginasesJA  K3 and  JAKl in Human 
T Celk  We recently have reported that IL-2 stimulates tyro- 
sine phosphorylation of the 125-kD JAK family kinaseJAK3 
and the 130-kD JAK1 (24). We therefore investigated directly 
whether IL-12 would stimulate tyrosine phosphorylation of 
these kinases. Immunoprecipitation  with polyclonal antiserum 
against  JAK3,  followed by antiphosphotyrosine blotting, 
confirmed that this kinase was phosphorylated on tyrosine 
in response to IL-2 (Fig. 3 A, lane 2) but clearly not in re- 
Figure  4.  lb.12 induces  phosphorylation of TYK2 and JAK2 in the 
NK3.3 cell line. NK3.3 cells (107) were incubated for 15 min in medium 
alone (lanes I and 3) Or with 100 U/ral IL-12 (lanes 2 and 4). Lysates were 
immunoprecipitated with antiserum to either TYK2 (lanes 1 and 2) or 
JAK2 (lanes 3 and 4). Imraunoprecipitates were resolved by SDS-PAGE 
and  analyzed  by antiphosphotyrosine imraunoblotting. 
sponse to IL-12 (lane 3). Similarly, antiphosphotyrosine im- 
munoblotting  ofJAK1 immunoprecipitates showed that tyro- 
sine phosphorylation of JAK1 was enhanced by stimulation 
of T cells with IL-2 (Fig. 3 B, lane 2) but not by IL-12 (lane 3). 
IL-12 Induces Tywsine  Phospkorflation of TYK2 and  JAK2 
in the Human NK Cell Line NK3.3.  Individual cytokines 
might induce phosphorylation of different JAK family ki- 
nases in different  cell types (22).  Because IL-12 has potent 
effects on NK cells, we investigated  the phosphorylation of 
TYK2 and JAK2 after IL-12 stimulation of the human NK 
cell line NK3.3. Lysates of unstimulated or IL-12-stimuhted 
NK3.~ cells were immunoprecipitated with antisera against 
JAK2 or TYK2and immunoblotted with antiphosphotyro- 
sine. Fig. 4  shows that in NK3.3 cells, like T  cells, IL-12 
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Figure 3.  1L-2,  but not 11.-12, induces tyrosinephos- 
phoryhtion of  JAK1 and JAK3. PHA-activated human 
T  cells  (2  x  107) were  incubated  for  15  rain  in 
medium alone (lanes I), with 1,000 U/ral Ib-2 (lanes 
2), or with 100 U/ral Ib12 (lanes 3). Lysates were ira- 
munoprecipitated with antiserum to either JAK3 (A) 
or JAK1  (B). Immunoprecipitates were resolved by 
SDS-PAGE and analyzed by antiphosphotyrosine im- 
munoblotting. treatment leads to tyrosine phosphorylation of both TYK2 
(lanes I and 2) and JAK2 (lanes 3 and 4). Since  NK3.3 cells 
are routinely cultured in the presence of IL-2, and thus ex- 
hibit  background levels of JAK3  phosphorylation, phos- 
phorylated JAK3 was immunoprecipitated in these experi- 
ments by the cross-reactive  JAK2 antiserum. JAK3, however, 
migrated slightly faster than JAK2, and its phosphorylation 
was clearly not altered by IL-12 treatment of the cells. Stim- 
ulation of NK3.3 cells by IL-2 was unable to induce tyrosine 
phosphorylation of TYK2 or JAK2 (data not shown). Addi- 
tionally, IL-2 stimulation of NK3.3 cells led to tyrosine phos- 
phorylation of JAK1 and JAK3, whereas stimulation with 
IL-12 did not (data not shown)  (24). 
Di~u~ion 
In this report, we demonstrate that IL-12 stimulation of 
human lymphocytes  results in the rapid tyrosine phosphory- 
lation of a number of cellular substrates, including the JAK 
family kinases TYK2 and JAK2. In contrast,  we show that 
IL-2 induces tyrosine phosphorylation of the kinases JAK1 
and JAK3 but not TYK2 or JAK2. 
Accumulating evidence supports a model of cytokine fig- 
n21ing whereby ligand binding induces homo- or heterodimeri- 
zation of receptor chains, leading to the formation of a mul- 
tiprotein signaling complex in which receptor-associated  JAK 
kinases are tyrosine phosphorylated and activated (13, 31). 
Our finding that IL-12 treatment of human lymphocytes leads 
to rapid tyrosine phosphorylation of TYK2 and JAK2 im- 
plicates these kinases in the immediate intracellular response 
to IL-12. Both TYK2 and JAK2 have been shown to be in- 
volved in the signal transduction pathways of other cytokine 
receptors, including the IFN (20, 21), IL-6 (22), and IL-3/IL- 
5/GM-CSF (23, 32) cytokine families. However, in contrast 
to their apparently promiscuous use by many cytokines, the 
tyrosine phosphorylation ofbothJAK2 and TYK2 by a single 
cytokine in multiple cell types thus far is unique to IL-12. 
Perhaps the combinatorial  use of JAKs is one means that 
different receptors use to achieve specificity in signaling. It 
will be important to determine the relative requirements for 
TYK2 and JAK2 in IL-12 signaling. 
As described above, while IL-12 and IL-2 have many similar 
functions, each also induces a variety of  distinct response (5-8). 
The molecular  basis for  such  functional redundancy and 
specificity  between cytokines is unclear. IL-12 and IL-2 cause 
tyrosine phosphorylation of related but distinct JAK kinases, 
the substrate spedficities of which have not yet been deter- 
mined. However, since these kinases are highly homologous 
(16), it is likely that some cell-signaling proteins will be sub- 
strates for all JAKS, while others will be phosphorylated only 
by certain family members. The similar biological functions 
of IL-2 and IL-12 might result from activation of common 
signaling pathways, while specific  effects might be produced 
by stimulation of unique pathways by the distinct combina- 
tion of  JAKs used by each cytokine. The ability of different 
cytokine receptor chains to bind cell signaling proteins and 
recruit them to a functional receptor-signaling complex where 
they may serve as substrates for JAK family kinases is also 
likely to be important in determining specificity of response 
from receptors that share signaling components. 
A likely set of substrates for the JAKs is the family of la- 
tent cytoplasmic transcription  factors termed STATs (signal 
transducers  and  activators  of transcription)  (31). Ligand 
binding to many cytokine receptors (such as gp130 and the 
IFN receptors) induces tyrosine phosphorylation of STAT 
family members that subsequently translocate to the nucleus, 
bind to related DNA sequences, and promote transcription 
(13, 31). It will be interesting to determine whether IL-12 
and IL-2 differentially  regulate unique or known STAT family 
members. 
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